[Rich66]

Trial info (London and Sutton)

http://clinicaltrials.gov/ct2/show/NCT00755885

Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer
This study is currently recruiting participants.
Verified by National Cancer Institute (NCI), July 2009
First Received: September 18, 2008 Last Updated: August 6, 2009 History of Changes

Sponsored by:	Cancer Research UK
Information provided by:	National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:	NCT00755885

Purpose RATIONALE: Abiraterone acetate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
PURPOSE: This phase I/II trial is studying the side effects and best dose of abiraterone acetate and to see how well it works in treating postmenopausal women with advanced or metastatic breast cancer.